Columbia University Medical Center

For TAVR Patients, TCEP Neuroprotection Procedure Is Safe

A multicenter trial has found that transcatheter cerebral embolic protection (TCEP)—a procedure designed to catch debris dislodged during transcatheter aortic valve replacement (TAVR) and thereby prevent neurological complications—is safe, provides effective capture of embolic debris, and does not change neurocognitive function for patients. More research is needed to investigate TCEP efficacy in terms of lowering brain lesion volume.

Results of the SENTINEL trial are published online and were presented today by Susheel Kodali, MD, associate professor of medicine at CUMC, at the Transcatheter Cardiovascular Therapeutics (TCT) conference.

Read more from the NewYork-Presbyterian newsroom: http://www.nyp.org/news/TAVR-Patients-Transcatheter-Cerebral-Embolic-Protection-is-Safe